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protistan infections
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ABSTRACT: Polymerase chain reaction (PCR) assays are useful tools for pathogen surveillance, but
they are only proxy indications of pathogen presence in that they detect a DNA sequence. To be useful for detection of actual infections, PCR assays must be thoroughly tested for sensitivity and specificity, and ultimately validated against a technique, typically histology, which allows visualization of
the parasite in host tissues. There is growing use of PCR assays for pathogen surveillance, but too
often the assumption is made that a positive PCR result verifies an infection in a tested host. This
assumption is valid only if the assay has been properly validated for the geographic area and for the
hosts examined. Researchers should interpret unvalidated PCR assay results with caution, and editors and reviewers should insist that robust validations support all assertions that PCR results confirm
infections.
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Polymerase chain reaction (PCR) assays are
extremely useful tools for pathogen surveillance in
aquatic animal pathology. It is important to remember,
however, that PCR-based techniques detect DNA
sequences (Hiney 2001); these sequences may or may
not be present in viable pathogen cells, and such cells
may or may not be from an established infection. PCRbased diagnostic methods are based on the accuracy of
the assumption that the positive signal is from the target species. Positive PCR assays may indicate the presence of an infectious agent, but the technique does not
verify the existence of an infection. In addition, falsepositives can be caused by poor specificity of PCR
primers and resulting cross-reaction with DNA of nontarget organisms (Claydon et al. 2004).
Conversely, negative PCR assays do not confirm the
absence of either targeted pathogen cells or infections.
False-negatives can result from sampling error due to
relatively small proportional abundances of pathogen
DNA (especially from hosts with localized or very light

infections) among the typically small DNA samples
that are analyzed (10 to 50 ng). Likewise, DNA sequence variations among different pathogen genetic
strains may inhibit PCR primer hybridization to target
DNA templates. Finally, inhibitors may be present in
the sample that affect DNA polymerases, whose efficient activities are critical to PCR assay performances
(Hiney 2001, Reece & Burreson 2004).
The focus here is exclusively on errors, misinterpretations, and unjustified consequences of unvalidated
assumptions that PCR amplifications of parasite target
DNA sequences verify infections. Infection occurs after
a host is exposed to a parasite, after the parasite overcomes external host barriers to invasion, and after the
parasite evades internal host defenses to become
established in target cells, tissues or organs. Because of
the possible misuse or misinterpretation of positive
findings from PCR assays alone, the OIE Aquatic Animal Health Standards Commission recently revised the
definition of infection from ‘the presence of a disease
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agent in a host’ to ‘the presence of a multiplying or
otherwise developing or latent disease agent in a host’
(OIE 2007, p. 9). PCR assays alone cannot determine
that a parasite has become established in a host. To be
interpreted appropriately, PCR-based analyses for
determination of protistan pathogen infections must be
validated against an established technique, typically
histology, which allows visualization of the infective
agent.
As defined by Hiney (2001), validation is an investigation of the extent to which a technique can be legitimately used for a particular purpose. Validation determines whether the technique detects the species,
whether it detects all strains and life history stages of
that species (inclusivity), and whether there is a crossreaction with any non-target species (exclusivity)
(Reece & Burreson 2004). The latter is particularly
problematic because it is impossible to test any assay
against all other organisms, so false positives from
unknown cross-reactions are always a possibility. This
becomes especially important if an assay is used in a
new host, or new geographic area for which it has not
been validated. Sequencing of amplification products
can verify that the DNA is from the target organism,
but it does not confirm that there is an actual infection.
Validation against histology determines the extent to
which the PCR assay detects an actual infection. Validation should be accomplished by field trials in which
the same sample is tested by both PCR-based methods
and histology. When using PCR assays to detect parasites in hosts or geographic regions where validation of
the assay has not been accomplished, infections must
be verified by histology. Of course, it is well documented through many validation studies that molecular diagnostic techniques are more sensitive than histology when infections are of low intensity, especially if
the parasite is small. In these circumstances, in situ
hybridization (ISH) assays may increase the sensitivity
of histology by facilitating visualization, and also provide assurance (when the ISH assay has been tested
for specificity) that the organism observed is the target
organism.
When using PCR assays to search for parasite DNA
in potential intermediate hosts, it is critical to confirm
infections with ISH assays. In such circumstances, the
morphology of parasite life cycle stages in an intermediate host may be different from their morphology in
the definitive host, so routine histology may be
ambiguous or misleading. ISH assays verify both the
identity of the parasite and confirm that the intermediate host is actually infected (Audemard et al. 2002).
Some recent publications highlight problems associated with over-interpretation of PCR-based diagnostic
results for protistan pathogens that were not properly
validated for the geographical region or hosts investi-

gated. Based on PCR analyses alone, Ulrich et al.
(2007) reported the presence of Haplosporidium nelsoni infections (causative agent of MSX disease) in
Crassostrea virginica and several other oyster species
in the Gulf of Mexico; these results indicated both geographic and host range expansions for H. nelsoni. The
PCR assay they used was developed by Stokes et al.
(1995). This assay has been tested for specificity with
other haplosporidians and local pathogens to the
extent possible, and has been validated for detection of
H. nelsoni in C. virginica in Chesapeake Bay. The
validation consisted of monthly comparisons of PCR
results and histology in 25 oysters through the
May–December infection period of H. nelsoni (N.
Stokes unpubl. data). The assay has not been validated
for the Gulf of Mexico. Ulrich et al. (2007) report that
‘30 of 41 oysters were positive for MSX’ (p. 196). They
also make the following statements: ‘…despite the
wide distribution of H. nelsoni infections’ (Abstract);
’…we are confident that these infections represent…’
(p. 197); ‘Given the … prevalence of infections in the
Gulf of Mexico…’ (p. 198); ‘We also identified H. nelsoni infections in oysters originating from …
Venezuela.’ (p. 198, all emphases mine). Ulrich et al.
(2007) acknowledge that they did not confirm infection
intensities by histology, but in reality they did not even
confirm actual infections. Nevertheless, they repeatedly assert the presence of infections, as shown above.
Clearly these authors have made an interesting finding
worthy of additional research, but they have not documented infections by H. nelsoni in C. virginica in the
Gulf of Mexico. In contrast, thousands of C. virginica
oysters from over 50 sites in the Gulf of Mexico that
were collected during all seasons of the year for over
20 yr have been examined histologically by competent
pathologists as part of the National Status and Trends
Program Mussel Watch Project (available at: ccma.nos.
noaa.gov/stressors/pollution/nsandt/), with no infection by H. nelsoni ever observed.
Other recent examples of misuse of PCR assay
results are those of Carrasco et al. (2007a,b), who
investigated the life cycles of Marteilia spp. (documented pathogens of oysters and mussels in Europe).
These authors used an unvalidated (sensu Hiney 2001)
PCR assay (López-Flores et al. 2004) to detect Marteilia
spp. DNA in zooplankton populations containing
potential intermediate hosts. No histology was performed on the samples and reported results are based
on PCR assays alone. Carrasco et al. (2007a) state that:
‘Identification of zooplankton species found infected
allowed two new Marteilia hosts to be proposed.’
(Abstract, emphasis mine). Throughout the Discussion
section of the paper the authors mention ‘infected’
samples. They state that: ‘The Marteilia parasite was
present in different groups of copepoda species and
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showed a lack of specificity. Therefore, other copepod
species could also probably have been infected…’
(p. 69, emphasis mine). Finally, the authors conclude
that there needs to be ‘…a more detailed study on the
role of the newly identified hosts in the life cycle of the
Marteilia parasite.’ (p. 69, emphasis mine).
In a subsequent paper, Carrasco et al. (2007b) use
the same unvalidated PCR assay to detect the presence
of Marteilia refringens DNA in zooplankton samples.
In their Table 1, they report the results of the PCR
assay as positive or negative, which is appropriate.
However, in the legend of both their Tables 1 and 2
they use the phrases ‘…zooplankton samples found to
be infected by Marteilia refringens…’ or ‘…zooplankton samples detected to be infected by Marteilia
refringens…’ (emphases mine). Furthermore, the following statement appears in the Results section:
‘Therefore, ecologically diverse marine crustacean
groups, such as calanoida, cyclopoida and harpacticoida copepods, and decapod crustacean larvae were
parasitized by M. refringens…’ (p. 1547, emphasis
mine). Finally, in the Discussion section it is stated that:
‘Copepod species more frequently found infected in
the present study were A. discaudata and Oithona sp.’
and ‘A number of zooplankton species were found to
be infected by the parasite using nested PCR.’ (p. 1549,
emphases mine). Other authors, to their credit, did not
report Marteilia sp. infections in copepods until they
were verified by an ISH assay (Audemard et al. 2002).
The interpretations of Carrasco et al. (2007a,b) are
especially troubling because M. refringens is an OIEreportable pathogen of molluscs and the presence of
infections can have potential economic consequences.
Therefore, for internationally reportable protistan
pathogens, researchers have a special obligation to
verify infections with a technique that allows visualization of the parasite.
In the studies mentioned above, PCR assay results
were interesting and certainly emphasize the need for
additional study, but in no case was infection of a host
by a parasite confirmed, though repeatedly asserted. I
urge researchers of protistan parasites to test their PCR
assays for specificity and to validate them against histology to empirically determine the limitations for
legitimate inferences on infection status that may be
concluded from PCR results. Only then is the assumption that a positive PCR result confirms an infection
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valid. PCR-only results from unvalidated assays that
are not confirmed by histology should be interpreted
with caution. Likewise, editors and reviewers of manuscripts reporting PCR diagnostic results must insist that
robust validations support all assertions that PCR
results confirm infections among tested hosts.
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